Macaskill EJ - Search Results

1

Neoadjuvant use of hormonal therapy in elderly patients with early or locally advanced hormone receptor-positive breast cancer.

Macaskill EJ, Renshaw L, Dixon JM. Macaskill EJ, et al. Oncologist. 2006 Nov-Dec;11(10):1081-8. doi: 10.1634/theoncologist.11-10-1081. Oncologist. 2006. PMID: 17110627 Free article. Review.

2

A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer.

McCaig FM, Renshaw L, Williams L, Young O, Murray J, Macaskill EJ, McHugh M, Hannon R, Dixon JM. McCaig FM, et al. Among authors: macaskill ej. Breast Cancer Res Treat. 2010 Feb;119(3):643-51. doi: 10.1007/s10549-009-0646-0. Breast Cancer Res Treat. 2010. PMID: 19941160 Clinical Trial.

3

Effects of fulvestrant 750mg in premenopausal women with oestrogen-receptor-positive primary breast cancer.

Young OE, Renshaw L, Macaskill EJ, White S, Faratian D, Thomas JS, Dixon JM. Young OE, et al. Among authors: macaskill ej. Eur J Cancer. 2008 Feb;44(3):391-9. doi: 10.1016/j.ejca.2007.11.007. Epub 2007 Dec 20. Eur J Cancer. 2008. PMID: 18083023 Clinical Trial.

4

Surgical issues surrounding use of aromatase inhibitors.

Dixon JM, Renshaw L, Murray J, Macaskill EJ, Young O, Miller WR. Dixon JM, et al. Among authors: macaskill ej. J Steroid Biochem Mol Biol. 2005 May;95(1-5):97-103. doi: 10.1016/j.jsbmb.2005.04.024. J Steroid Biochem Mol Biol. 2005. PMID: 16023854

5

Neoadjuvant use of endocrine therapy in breast cancer.

Macaskill EJ, Dixon JM. Macaskill EJ, et al. Breast J. 2007 May-Jun;13(3):243-50. doi: 10.1111/j.1524-4741.2007.00417.x. Breast J. 2007. PMID: 17461898 Review.

6

DCIS and aromatase inhibitors.

Dixon JM, Faratian D, White S, Renshaw L, Murray J, Young O, Macaskill EJ, Williams L, Thomas J, Evans DB. Dixon JM, et al. Among authors: macaskill ej. J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):173-9. doi: 10.1016/j.jsbmb.2007.05.015. Epub 2007 May 24. J Steroid Biochem Mol Biol. 2007. PMID: 17604618

7

Increase in response rate by prolonged treatment with neoadjuvant letrozole.

Dixon JM, Renshaw L, Macaskill EJ, Young O, Murray J, Cameron D, Kerr GR, Evans DB, Miller WR. Dixon JM, et al. Among authors: macaskill ej. Breast Cancer Res Treat. 2009 Jan;113(1):145-51. doi: 10.1007/s10549-008-9915-6. Epub 2008 Feb 9. Breast Cancer Res Treat. 2009. PMID: 18264759 Clinical Trial.

8

Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer.

Dixon JM, Renshaw L, Young O, Murray J, Macaskill EJ, McHugh M, Folkerd E, Cameron DA, A'Hern RP, Dowsett M. Dixon JM, et al. Among authors: macaskill ej. J Clin Oncol. 2008 Apr 1;26(10):1671-6. doi: 10.1200/JCO.2007.13.9279. J Clin Oncol. 2008. PMID: 18375896 Clinical Trial.

9

Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability.

Dixon JM, Renshaw L, Langridge C, Young OE, McHugh M, Williams L, Murray J, Macaskill EJ, McCaig F, Dixon OM, Fallowfield LJ. Dixon JM, et al. Among authors: macaskill ej. Breast Cancer Res Treat. 2011 Feb;125(3):741-9. doi: 10.1007/s10549-010-1091-9. Epub 2010 Sep 7. Breast Cancer Res Treat. 2011. PMID: 20821047 Clinical Trial.

10

Surgeons' views on multi-disciplinary breast meetings.

Macaskill EJ, Thrush S, Walker EM, Dixon JM. Macaskill EJ, et al. Eur J Cancer. 2006 May;42(7):905-8. doi: 10.1016/j.ejca.2005.12.014. Epub 2006 Mar 3. Eur J Cancer. 2006. PMID: 16516461

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page